首页>美国卫生研究院文献>Therapeutic Advances in Hematology

Therapeutic Advances in Hematology

【机译】：在血液科治疗进展

ISSN：-
出版周期：Bimonthly
语言：English

起始发布年份：2010
出版者：London : Sage
出版地：England

数据库引入：PubMed: v1n1, 2010-, PMC

MeSH词表主题词：Hematologic Diseases/therapy*; Hematology

备注：Vol. 1 complete in one issue. Also issued online. Description based on: Vol. 2,展开▼

期刊论文

热门论文

年度选择

更多>>

全选（0）

1.Subcutaneous daratumumab and hyaluronidase-fihj in newly diagnosed or relapsed/refractory multiple myeloma

机译：在新诊断或复发/难治性多发性骨髓瘤中皮下的小蚁尤曼和透明质酸酶-FIHJ
- 作者：Larysa Sanchez;Joshua Richter;Hearn Jay Cho;Sundar Jagannath;Deepu Madduri;Samir Parekh;Shambavi Richard;Lowena Tam;Daniel Verina;Ajai Chari
- 期刊名称：《Therapeutic Advances in Hematology》 | 2021年第-1期
- CD38;
- daratumumab;
- monoclonal antibody;
- multiple myeloma;
- myeloma;
- newly diagnosed;
- relapsed refractory;
- subcutaneous;
2.Relapsed/refractory multiple myeloma-transformed plasma-cell leukemia successfully treated with daratumumab followed by autologous stem cell transplantation

机译：复发/难治性多发性骨髓瘤转化的等离子体细胞白血病用达拉穆曼成功处理然后进行自体干细胞移植
- 作者：Chen-lu Yang;Neng-gang Jiang;Li Zhang;Kai Shen;Yu Wu
- 期刊名称：《Therapeutic Advances in Hematology》 | 2021年第-1期
- plasma-cell leukemia;
- daratumumab;
- immunomodulatory effect;
3.Rituximab in combination with cyclophosphamide doxorubicin vincristine and prednisone (R-CHOP) in diffuse large B-cell lymphoma

机译：Rituximab与环磷酰胺多柔比蛋白长春酮和泼尼松（R-Chec）组合在弥漫性大B细胞淋巴瘤中
- 作者：Myrna Candelaria;Alfonso Dueñas-Gonzalez
- 期刊名称：《Therapeutic Advances in Hematology》 | 2021年第-1期
- chemoimmunotherapy;
- diffuse large B-cell lymphoma;
- non-Hodgkin lymphoma treatment;
- R-CHOP;
- rituximab biosimilars;
4.B-cell maturation antigen (BCMA) in multiple myeloma: the new frontier of targeted therapies

机译：多发性骨髓瘤中的B细胞成熟抗原（BCMA）：目标疗法的新前沿
- 作者：Larysa Sanchez;Alexandra Dardac;Deepu Madduri;Shambavi Richard;Joshua Richter
- 期刊名称：《Therapeutic Advances in Hematology》 | 2021年第-1期
5.Current and novel BTK inhibitors in Waldenström’s macroglobulinemia

机译：Waldenström的麦克风癌血症的当前和新型BTK抑制剂
- 作者：Ioannis Ntanasis-Stathopoulos;Maria Gavriatopoulou;Despina Fotiou;Meletios A. Dimopoulos
- 期刊名称：《Therapeutic Advances in Hematology》 | 2021年第-1期
- Bruton’s tyrosine kinase;
- ibrutinib;
- MYD88;
- Waldenstrom’s macroglobulinemia;
- zanubrutinib;
6.The evolving role of Bruton’s tyrosine kinase inhibitors in chronic lymphocytic leukemia

机译：布鲁顿酪氨酸激酶抑制剂在慢性淋巴细胞白血病中的不断发展作用
- 作者：Max J. Gordon;Alexey V. Danilov
- 期刊名称：《Therapeutic Advances in Hematology》 | 2021年第-1期
- chronic lymphocytic leukemia;
- ibrutinib;
- acalabrutinib;
- BTK inhibitor;
- combination therapy;
- targeted therapy;
7.The role of acalabrutinib in adults with chronic lymphocytic leukemia

机译：Acalabrutinib在慢性淋巴细胞白血病成年人中的作用
- 作者：Bita Fakhri;Charalambos Andreadis
- 期刊名称：《Therapeutic Advances in Hematology》 | 2021年第-1期
- chronic lymphocytic leukemia;
- small lymphocytic lymphoma;
- bruton tyrosine kinase inhibitors;
- BTK inhibitors;
- acalabrutinib;
- ibrutinib;
8.Case report: successful perioperative management of patients with haemophilia A using an extended half-life factor VIII (Efmoroctocog alfa) during neurosurgical procedures

机译：案例报告：在神经外科手术期间使用延长半衰期VIII（EFMOROCTOCOG ALFA）的血友病患者的成功围手术期管理
- 作者：Florian Kocher;Andreas Seeber;Johannes Kerschbaumer;Stefan Schmidt;Dominik Wolf;Clemens Feistritzer
- 期刊名称：《Therapeutic Advances in Hematology》 | 2021年第-1期
- haemophilia A;
- neurosurgical procedure;
- perioperative management;
- rFVIIIFc;
9.Concurrent application of blinatumomab and haploidentical donor leukocyte infusions for refractory primary mediastinal large B-cell lymphoma

机译：Blinatumomab和Haploidentical供体白细胞抑制难治性原发性纵隔大B细胞淋巴瘤的同时应用
- 作者：Jasmine Smith;Abhijeet Kumar;Natalie A. Stanton;Emmanuel Katsanis
- 期刊名称：《Therapeutic Advances in Hematology》 | 2021年第-1期
- blinatumomab;
- DLI;
- haploidentical-BMT;
- PMBCL;
10.Current treatment options for aggressive non-Hodgkin lymphoma in elderly and frail patients: practical considerations for the hematologist

机译：对老年人和脆弱患者进行侵袭性非霍奇金淋巴瘤的当前治疗方案：血液学学者的实际考虑因素
- 作者：Katrin Schmittlutz;Reinhard Marks
- 期刊名称：《Therapeutic Advances in Hematology》 | 2021年第-1期
- cardiotoxicity;
- comorbidity;
- elderly;
- frail;
- non-Hodgkin lymphoma;
11.Bortezomib-based therapy in non-transplant multiple myeloma patients:a retrospective cohort study from the FABIO project

机译：基于Bortezomib的非移植多发性骨髓瘤治疗患者：Fabio项目的回顾性队列研究
- 作者：Matteo Franchi;Claudia Vener;Donatella Garau;Ursula Kirchmayer;Mirko Di Martino;Marilena Romero;Ilenia De Carlo;Salvatore Scondotto;Chiara Stival;Matteo Giovanni Della Porta;Francesco Passamonti;Giovanni Corrao
- 期刊名称：《Therapeutic Advances in Hematology》 | 2021年第-1期
- multiple myeloma;
- bortezomib;
- effectiveness;
- cost-effectiveness;
- real-world;
12.Cytomegalovirus prophylaxis using low-dose valganciclovir in patients with acute leukemia undergoing allogeneic hematopoietic stem-cell transplantation

机译：患有低剂量Valganciclovir在患有同种异体白血病患者中进行同种异体白血病患者的巨细胞病毒预防
- 作者：Po-Hsien Li;Cheng-Hsien Lin;Yu-Hui Lin;Tsung-Chih Chen;Chiann-Yi Hsu;Chieh-Lin Jerry Teng
- 期刊名称：《Therapeutic Advances in Hematology》 | 2021年第-1期
- allo-HSCT;
- CMV;
- leukemia;
- prophylaxis;
- valganciclovir;
13.Current evidence and the emerging role of eltrombopag in severe aplastic anemia

机译：当前的证据和Eltompopag在严重血栓性贫血中的新兴作用
- 作者：Beatrice Drexler;Jakob Passweg
- 期刊名称：《Therapeutic Advances in Hematology》 | 2021年第-1期
- aplastic anemia;
- eltrombopag;
14.Voxelotor: alteration of sickle cell disease pathophysiology by a first-in-class polymerization inhibitor

机译：Voxelotor：通过一类级别的聚合抑制剂改变镰状细胞病理病理学病理学
- 作者：Alexander K. Glaros;Reza Razvi;Nirmish Shah;Ahmar U. Zaidi
- 期刊名称：《Therapeutic Advances in Hematology》 | 2021年第-1期
- Sickle cell disease;
- voxelotor;
- novel therapeutics;
- hemoglobin polymerization;
15.Advances in therapeutic options for newly diagnosed high-risk AML patients

机译：新诊断高风险AML患者治疗选择的进展
- 作者：Kimberley Doucette;Judith Karp;Catherine Lai
- 期刊名称：《Therapeutic Advances in Hematology》 | 2021年第-1期
- acute myeloid leukemia;
- adverse risk;
- high risk;
- newly diagnosed;
- therapy;
16.Thrombopoietin receptor agonist for treatment of immune thrombocytopenia in pregnancy: a narrative review

机译：血小板生成素受体激动剂治疗免疫血小板减少症怀孕：叙事综述
- 作者：Nikki Agarwal;Ankit Mangla
- 期刊名称：《Therapeutic Advances in Hematology》 | 2021年第-1期
- avatrombopag;
- eltrombopag;
- immune thrombocytopenia;
- pregnancy;
- romiplostim;
- thrombopoietin receptor agonists;
17.Safety and efficacy of a single total dose infusion (1020 mg) of ferumoxytol

机译：单一剂量输注（1020mg）的Ferumoxytol的安全性和有效性
- 作者：Harris Khan;Paige May;Elim Kuo;Preetika Pai;Katherine Boles;Ashley McGee;Tanaka Dang;Jessica Schmit
- 期刊名称：《Therapeutic Advances in Hematology》 | 2021年第-1期
- iron;
- iron compounds;
- iron-deficiency anemia;
- ferumoxytol;
18.Update on the role of copanlisib in hematologic malignancies

机译：更新Copanlisib在血液学恶性肿瘤中的作用
- 作者：Thuy Le;David Jerel;Locke J. Bryan
- 期刊名称：《Therapeutic Advances in Hematology》 | 2021年第-1期
- copanlisib;
- lymphoma;
- PI3K;
- targeted therapy;
19.Expert opinion on the UK standard of care for haemophilia patients with inhibitors: a modified Delphi consensus study

机译：英国血友病患者抑制剂患者的专家意见：改良的Delphi共识研究
- 作者：Kate Khair;Elizabeth Chalmers;Thuvia Flannery;Annabel Griffiths;Felicity Rowley;Guillermo Tobaruela;Pratima Chowdary
- 期刊名称：《Therapeutic Advances in Hematology》 | 2021年第-1期
- adult;
- children;
- consensus;
- Delphi panel;
- haemophilia;
- inhibitors;
20.A novel treatment regimen of granulocyte colony-stimulating factor combined with ultra-low-dose decitabine and low-dose cytarabine in older patients with acute myeloid leukemia and myelodysplastic syndromes

机译：粒细胞菌落刺激因子的新型治疗方案与老年骨髓白血病和髓细胞增强综合症的老年患者超低剂量脱蛋白和低剂量含有低剂量红霉菌症
- 作者：Huan Zhu;Bin Yang;Jia Liu;Biao Wang;Yicun Wu;Zhuojun Zheng;Yun Ling
- 期刊名称：《Therapeutic Advances in Hematology》 | 2021年第-1期
- acute myeloid leukemia;
- low-dose cytarabine;
- myelodysplastic syndromes;
- older patients;
- ultra-low-dose decitabine;
21.Assessment of thrombotic risk during long-term treatment of immune thrombocytopenia with fostamatinib

机译：用FOSTAMATINIB的长期治疗免疫血小板减少症期间的血栓性风险评估
- 作者：Nichola Cooper;Ivy Altomare;Mark R. Thomas;Phillip L. R. Nicolson;Steve P. Watson;Vadim Markovtsov;Leslie K. Todd;Esteban Masuda;James B. Bussel
- 期刊名称：《Therapeutic Advances in Hematology》 | 2021年第-1期
- arterial thrombosis;
- disorders of platelet function;
- immune thrombocytopenic purpura;
- platelets;
- venous thrombosis;
22.Treatment with eltrombopag of severe immune thrombocytopenia and hemolytic anemia associated with COVID-19 pneumonia: a case report

机译：用Covid-19肺炎的严重免疫血小板减少血症和溶血性贫血的Eltrombopag治疗：案例报告
- 作者：Gabriella Gruden;Eloise Beggiato;Enrica Camerino;Serena Capriotti;Silvia Canepa;Michela Scandella;Maria Avolio;Fabrizia Pittalunga;Federica Barutta;Marilena Durazzo
- 期刊名称：《Therapeutic Advances in Hematology》 | 2021年第-1期
- case report;
- COVID-19;
- eltrombopag;
- hemolytic anemia;
- immune thrombocytopenia;
23.Busulfan plus melphalan

机译：Busulfan Plus Melphalan.
- 作者：Songyi Park;Dong-Yeop Shin;Junshik Hong;Inho Kim;Youngil Koh;Ja Min Byun;Sung-Soo Yoon
- 期刊名称：《Therapeutic Advances in Hematology》 | 2021年第-1期
- autologous stem cell transplantation;
- busulfan;
- conditioning regimen;
- melphalan;
- multiple myeloma;
24.Treosulfan-based conditioning for inborn errors of immunity

机译：基于三胞素的抗扰度的调节
- 作者：Mary A. Slatter;Andrew R. Gennery
- 期刊名称：《Therapeutic Advances in Hematology》 | 2021年第-1期
- inborn errors of immunity;
- haematopoietic stem cell transplantation;
- treosulfan;
25.Prognostic molecular biomarkers in diffuse large B-cell lymphoma in the rituximab era and their therapeutic implications

机译：预后分子生物标志物在人民币时代弥漫性大B细胞淋巴瘤及其治疗意义
- 作者：Sotirios G. Papageorgiou;Thomas P. Thomopoulos;Ioannis Katagas;Anthi Bouchla;Vassiliki Pappa
- 期刊名称：《Therapeutic Advances in Hematology》 | 2021年第-1期
- ABC;
- biomarkers;
- COO;
- DLBCL;
- double-expressor;
- double-hit;
- GCB;
- GEP;
- prognosis;
- tumor microenvironment;
26.The role of tazemetostat in relapsed/refractory follicular lymphoma

机译：Tazemetostat在复发/难治性滤泡淋巴瘤中的作用
- 作者：Gottfried von Keudell;Gilles Salles
- 期刊名称：《Therapeutic Advances in Hematology》 | 2021年第-1期
- clinical trial;
- Enhancer of zester homologue 2 (EZH2);
- epigenetic;
- follicular lymphoma;
- targeted therapy;
27.The role of axicabtagene ciloleucel as a treatment option for patients with follicular/marginal zone lymphoma

机译：AxicabTagene Cileleucel作为卵泡/边缘区淋巴瘤患者的治疗选择的作用
- 作者：Jose Sandoval-Sus;Julio C. Chavez
- 期刊名称：《Therapeutic Advances in Hematology》 | 2021年第-1期
- axi-cel;
- CAR-T;
- follicular lymphoma;
- marginal zone lymphoma;
28.Ferumoxytol for the treatment of iron deficiency and iron-deficiencyanemia of pregnancy

机译：ferumoxytol用于治疗缺铁和缺铁怀孕的贫血
- 作者：Jesse Gerb;William Strauss;Richard Derman;Vanessa Short;Ben Mendelson;Huzefa Bahrain;Michael Auerbach
- 期刊名称：《Therapeutic Advances in Hematology》 | 2021年第-1期
- intravenous iron;
- iron deficiency;
- pregnancy;
- total dose infusion;
29.Maintenance therapy for untreated diffuse large B-cell lymphoma: a systematic review and network meta-analysis

机译：未处理弥漫性大型B细胞淋巴瘤的维持治疗：系统审查和网络元分析
- 作者：Ting Yuan;Feng Zhang;Qingmin Yao;Yanxia Liu;Xiaojuan Zhu;Peng Chen
- 期刊名称：《Therapeutic Advances in Hematology》 | 2021年第-1期
- chemotherapy;
- diffuse large B-cell lymphoma;
- maintenance therapy;
- meta-analysis;
- targeted therapy;
30.The role of idecabtagene vicleucel in patients with heavilypretreated refractory multiple myeloma

机译：IdeCabTagene viceucel在患者中的作用预处理难治性多发性骨髓瘤
- 作者：Albert Oriol;Laura Abril;Anna Torrent;Gladys Ibarra;Josep-Maria Ribera
- 期刊名称：《Therapeutic Advances in Hematology》 | 2021年第-1期
31.Natural-killer cell cytotoxicity as a diagnostic and prognostic marker for adult patients with secondary hemophagocytic lymphohistiocytosis: a prospective phase II observational study

机译：天然杀伤细胞细胞毒性作为成人患者患有次生血糖淋巴管症的诊断和预后标志物：一项潜在期II的观察研究
- 作者：Eun-Jee Oh;Jae-Ho Yoon;Ki Hyun Park;Hyun Joo Bae;So Jeong Yun;Gi June Min;Sung-Soo Park;Silvia Park;Sung-Eun Lee;Byung-Sik Cho;Ki-Seong Eom;Yoo-Jin Kim;Seok Lee;Hee-Je Kim;Chang-Ki Min;Seok-Goo Cho;Kyungja Han;Jong Wook Lee
- 期刊名称：《Therapeutic Advances in Hematology》 | 2021年第-1期
- cytotoxicity;
- febrile disease;
- hemophagocytic lymphohistiocytosis;
- natural-killer cell;
32.A rare atypical chronic myeloid leukemia BCR-ABL1 negative withconcomitant JAK2 V617F and SETBP1 mutations: acase report and literature review

机译：罕见的非典型慢性骨髓白血病BCR-ABL1负伴随JAK2 V617F和SETBP1突变：a案例报告和文献综述
- 作者：Tianqi Gao;Changhui Yu;Si Xia;Ting Liang;Xuekui Gu;Zenghui Liu
- 期刊名称：《Therapeutic Advances in Hematology》 | 2020年第-1期
33.Early precursor T-cell acute lymphoblastic leukemia: current paradigms and evolving concepts

机译：早期前体T细胞急性淋巴细胞白血病：目前的范式和不断发展的概念
- 作者：Omar Castaneda Puglianini;Nikolaos Papadantonakis
- 期刊名称：《Therapeutic Advances in Hematology》 | 2020年第-1期
34.Gilteritinib in the treatment of relapsed and refractory acutemyeloid leukemia with a FLT3 mutation

机译：Gilteritinib在复发和难治性急性的处理中骨髓白血病具有FLT3突变
- 作者：Serena Chew;Melissa C. Mackey;Elias Jabbour
- 期刊名称：《Therapeutic Advances in Hematology》 | 2020年第-1期
35.Selinexor in relapsed/refractory multiple myeloma

机译：Selinexor复发/难治性多发性骨髓瘤
- 作者：Joshua Richter;Deepu Madduri;Shambavi Richard;Ajai Chari
- 期刊名称：《Therapeutic Advances in Hematology》 | 2020年第-1期
36.Experiences of allogeneic hematopoietic cell transplantationfollowing non-myeloablative conditioning regimen in severely comorbid patientswith myelofibrosis: case series with a patient presenting with extensiveextramedullary hematopoiesis

机译：同种异体造血细胞移植的经验在严重的合并患者中非髓鞘调理方案用骨髓纤维化：案例系列与患者呈现广泛extramedullary血液缺血
- 作者：Jae-Ho Yoon;Sung-Soo Park;Gi June Min;Silvia Park;Sung-Eun Lee;Byung-Sik Cho;Yoo-Jin Kim;Seok Lee;Hee-Je Kim;Chang-Ki Min;Seok-Goo Cho;Jong Wook Lee;Ki-Seong Eom
- 期刊名称：《Therapeutic Advances in Hematology》 | 2020年第-1期
37.BRD4 inhibitor nitroxoline enhances the sensitivity of multiplemyeloma cells to bortezomib in vitro and invivo by promoting mitochondrial pathway-mediated cellapoptosis

机译：BRD4抑制剂Nitroxoline增强了多个的灵敏度骨髓瘤细胞在体外和体外硼替佐米通过促进线粒体途径介导细胞的体内凋亡
- 作者：Guang Li;Yan-Hua Zheng;Li Xu;Juan Feng;Hai-Long Tang;Cheng Luo;Yan-Ping Song;Xie-Qun Chen
- 期刊名称：《Therapeutic Advances in Hematology》 | 2020年第-1期
38.Anti-leukemic effect of CDK9 inhibition in T-cell prolymphocytic leukemia

机译：抗白血病抑制在T细胞Plosmphocytic白血病中的抑制作用
- 作者：Patricia Johansson;Laura Dierichs;Ludger Klein-Hitpass;Anke K. Bergmann;Michael Möllmann;Sascha Menninger;Peter Habenberger;Bert Klebl;Jens T. Siveke;Ulrich Dührsen;Axel Choidas;Jan Dürig
- 期刊名称：《Therapeutic Advances in Hematology》 | 2020年第-1期
39.HLA-mismatched donor and high ferritin level showed poor clinical outcomes after allogeneic hematopoietic cell transplantation in patients with advanced myelofibrosis

机译：HLA - 不匹配的供体和高铁蛋白水平显示出在先进的肌纤维化患者患者中同种异体造血细胞移植后的临床结果差
- 作者：Jae-Ho Yoon;Gi June Min;Sung-Soo Park;Silvia Park;Sung-Eun Lee;Byung-Sik Cho;Yoo-Jin Kim;Seok Lee;Hee-Je Kim;Chang-Ki Min;Seok-Goo Cho;Jong Wook Lee;Ki-Seong Eom
- 期刊名称：《Therapeutic Advances in Hematology》 | 2020年第-1期
40.Letermovir and its role in the prevention of cytomegalovirus infection in seropositive patients receiving an allogeneic hematopoietic cell transplant

机译：Letermovir及其在接受同种异体造血细胞移植的血清阳性患者中预防细胞核病毒感染的作用
- 作者：Terri Lynn Shigle;Victoria Wehr Handy;Roy F. Chemaly
- 期刊名称：《Therapeutic Advances in Hematology》 | 2020年第-1期
41.Effective treatment of refractory acquired pure red bloodcell aplasia with eltrombopag and sirolimus: a casereport

机译：有效治疗难治性获得的纯红色血液具有Eltompagag和Sirolimus的细胞Aplasia：一种情况报告
- 作者：Yuzhou Huang;Xianyong Jiang;Bing Han
- 期刊名称：《Therapeutic Advances in Hematology》 | 2020年第-1期
42.Low dose continuous lenalidomide in heavily pretreated patients with relapsed or refractory classical Hodgkin lymphoma: a retrospective case series

机译：低剂量连续的Lenalidomide在重复或难治性经典霍奇金淋巴瘤的重复预处理患者：回顾性案例系列
- 作者：Helen Ma;Bin Cheng;Francesca Montanari;Jennifer K. Lue;Changchun Deng;Enrica Marchi;Owen A. O’ Connor;Ahmed Sawas
- 期刊名称：《Therapeutic Advances in Hematology》 | 2020年第-1期
43.Advances in the understanding of poor graft function following allogeneic hematopoietic stem-cell transplantation

机译：同种异体造血干细胞移植后对差移植功能的理解的进展
- 作者：Juan Chen;Hongtao Wang;Jiaxi Zhou;Sizhou Feng
- 期刊名称：《Therapeutic Advances in Hematology》 | 2020年第-1期
44.Overt and non-overt disseminated intravascular coagulation and the potential role of heparin in the COVID-19 pandemic outbreak

机译：公开和非公开播散血管内凝血和肝素在Covid-19大流行爆发中的潜在作用
- 作者：Francesca Salamanna;Maria Paola Landini;Milena Fini
- 期刊名称：《Therapeutic Advances in Hematology》 | 2020年第-1期
45.Current and novel therapies for the prevention of vaso-occlusive crisis in sickle cell disease

机译：在镰状细胞疾病中预防血管闭塞危机的当前和新疗法
- 作者：Ifeyinwa Osunkwo;Deepa Manwani;Julie Kanter
- 期刊名称：《Therapeutic Advances in Hematology》 | 2020年第-1期
46.Quality-of-life issues and symptoms reported by patients living withhaematological malignancy: a qualitative study

机译：患者的生活质量问题和症状血液恶性肿瘤：一个定性研究
- 作者：Pushpendra Goswami;Esther N. Oliva;Tatyana Ionova;Roger Else;Jonathan Kell;Adele K. Fielding;Daniel M. Jennings;Marina Karakantza;Saad Al-Ismail;Graham P. Collins;Stewart McConnell;Catherine Langton;Sam Salek
- 期刊名称：《Therapeutic Advances in Hematology》 | 2020年第-1期
47.Emerging treatment options for patients with high-riskmyelodysplastic syndrome

机译：高风险患者的新出现治疗选择骨髓增生异常综合症
- 作者：Jan Philipp Bewersdorf;Hetty Carraway;Thomas Prebet
- 期刊名称：《Therapeutic Advances in Hematology》 | 2020年第-1期
48.Primary lymphoma of bone: a population-based study of 2558 patients

机译：骨髓淋巴瘤：对2558例患者的基于人群的研究
- 作者：Chen-Xin Liu;Tian-Qi Xu;Li Xu;Pan-Pan Wang;Chun Cao;Guang-Xun Gao;Yan-Hua Zheng
- 期刊名称：《Therapeutic Advances in Hematology》 | 2020年第-1期
49.High CXCR2 expression predicts poor prognosis in adult patients with acute myeloid leukemia

机译：高CXCR2表达预测成人患者急性髓细胞白血病的预后不良
- 作者：Wei Tang;Zunyan Li;Xian Li;Zhonghua Huo
- 期刊名称：《Therapeutic Advances in Hematology》 | 2020年第-1期
50.Rescue treatment with eltrombopag in refractory cytopenias afterallogeneic stem cell transplantation

机译：在难治性cytopenias中用Eltrombopag拯救治疗同种异体干细胞移植
- 作者：Semra Aydin;Chiara Dellacasa;Sara Manetta;Luisa Giaccone;Laura Godio;Giorgia Iovino;Benedetto Bruno;Alessandro Busca
- 期刊名称：《Therapeutic Advances in Hematology》 | 2020年第-1期
51.Older-age onset of Kimura’s disease

机译：Kimura疾病的较老年人发病
- 作者：Eiichi Kakehi;Kazuhiko Kotani;Tsubasa Yoshida;Tsubasa Nakai;Shigehisa Sakurai;Akane Hirotani;Kaduyo Simizu;Takafumi Nozaki;Keisuke Shoji;Seiji Adachi;Masami Matsumura
- 期刊名称：《Therapeutic Advances in Hematology》 | 2020年第-1期
52.Co-transplantation of mesenchymal stem cells makes haploidentical HSCT a potential comparable therapy with matched sibling donor HSCT for patients with severe aplastic anemia

机译：间充质干细胞的共移植使HAPLoIdentical HSCT具有匹配的Sibling供体HSCT对严重血栓性贫血患者的潜在类似的疗法
- 作者：Zenghui Liu;Xiaoxiong Wu;Shunqing Wang;Linghui Xia;Haowen Xiao;Yonghua Li;Hongbo Li;Yuping Zhang;Duorong Xu;Danian Nie;Yongrong Lai;Bingyi Wu;Dongjun Lin;Xin Du;Zujun Jiang;Yang Gao;Xuekui Gu;Yang Xiao
- 期刊名称：《Therapeutic Advances in Hematology》 | 2020年第-1期
53.Posaconazole for the prophylaxis of invasive aspergillosis in acute myeloid leukemia: Is it still useful outside the clinical trial setting?

机译：posaconazole用于急性髓性白血病中侵袭性曲霉病的预防：它仍然有用外面有用吗？
- 作者：Tsung-Chih Chen;Ren Ching Wang;Yu-Hui Lin;Kuang-Hsi Chang;Li-Ya Hung;Chieh-Lin Jerry Teng
- 期刊名称：《Therapeutic Advances in Hematology》 | 2020年第-1期
54.Tyrosine kinase inhibitors and pregnancy in chronic myeloid leukemia: opinion evidence and recommendations

机译：慢性骨髓白血病酪氨酸激酶抑制剂和妊娠：意见证据和建议
- 作者：Elisabetta Abruzzese;Michael Mauro;Jane Apperley;Ekaterina Chelysheva
- 期刊名称：《Therapeutic Advances in Hematology》 | 2020年第-1期
55.Serum ferritin and ECOG performance status predict the response and improve the prognostic value of IPSS or IPSS-R in patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia treated with 5-azacytidine: a retrospective analysis of the Hellenic national registry of myelodysplastic and hypoplastic syndromes

机译：血清铁蛋白和ECOG性能状况预测了用5-氮杂胞苷治疗的高风险髓霉菌综合征和寡粒细胞急性霉菌白血病患者IPS或IPSS-R的响应和提高响应性的响应和改善IPS-R的预后价值：HELEELODYSPLASTACTIC和HEALENIC NERICAL REVISE的回顾性分析hypoplastic综合征
- 作者：Sotirios G. Papageorgiou;Ioannis Kotsianidis;Anthi Bouchla;Argyris Symeonidis;Athanasios Galanopoulos;Nora-Athina Viniou;Eleftheria Hatzimichael;Theodoros P. Vassilakopoulos;Dimitrios Gogos;Aikaterini Megalakaki;Panagiotis Zikos;Panagiotis Diamantopoulos;Alexandra Kourakli;Panagiota Giannoulia;Menelaos Papoutselis;Elias Poulakidas;Maria Arapaki;Anna Vardi;Achilles Anagnostopoulos;Despoina Mparmparousi;Maria Papaioannou;Eleni Bouronikou;Maria Dimou;Helen Papadaki;Panayiotis Panayiotidis;Vasiliki Pappa
- 期刊名称：《Therapeutic Advances in Hematology》 | 2020年第-1期
56.One-year efficacy and safety of ravulizumab in adults with paroxysmalnocturnal hemoglobinuria naïve to complement inhibitor therapy: open-labelextension of a randomized study

机译：患有阵发性的成年人的一年疗效和安全性夜间血红蛋白尿以补充抑制剂治疗：开放标签延长随机研究
- 作者：Hubert Schrezenmeier;Austin Kulasekararaj;Lindsay Mitchell;Flore Sicre de Fontbrune;Timothy Devos;Shinichiro Okamoto;Richard Wells;Scott T. Rottinghaus;Peng Liu;Stephan Ortiz;Jong Wook Lee;Gérard Socié
- 期刊名称：《Therapeutic Advances in Hematology》 | 2020年第-1期
57.Pharmacokinetics in routine haemophilia clinical practice: rationaleand modalities—a practical review

机译：常规六种嗜血症症临床实践中的药代动力学：理由和模态 - 实际审查
- 作者：Cedric Hermans;Gerry Dolan
- 期刊名称：《Therapeutic Advances in Hematology》 | 2020年第-1期
58.CMV retinitis in a stem cell transplant recipient treated with foscarnet intravitreal injection and CMV specific immunoglobulins

机译：CMV视网膜炎在干细胞移植受体中用Foscarnet玻璃体内注射治疗和CMV特异性免疫球蛋白处理
- 作者：Francesco Vassallo;Raffaele Nuzzi;Ilaria Cattani;Chiara Dellacasa;Luisa Giaccone;Francesco Giuseppe De Rosa;Rossana Cavallo;Giorgia Iovino;Lucia Brunello;Benedetto Bruno;Alessandro Busca
- 期刊名称：《Therapeutic Advances in Hematology》 | 2020年第-1期
59.Adverse events in second- and third-line treatments for acute and chronic graft-versus-host disease: systematic review

机译：急性和慢性移植术 - 与宿主疾病的第二和第三线治疗中的不良事件：系统评价
- 作者：Vladica M. Velickovic;Emily McIlwaine;Rongrong Zhang;Tim Spelman
- 期刊名称：《Therapeutic Advances in Hematology》 | 2020年第-1期
60.Disseminated focal 18F-fluoro-deoxyglucose uptake upon granulocytecolony-stimulating factor therapy mimicking malignant bone infiltration: case report of apatient with very severe aplastic anemia

机译：造粒于粒细胞上的焦点18F-氟 - 脱氧葡萄糖摄取殖民地刺激因子疗法模仿恶性骨渗透：案例报告患有非常严重的贫血性贫血
- 作者：Lena Horvath;Andreas Seeber;Christian Uprimny;Dominik Wolf;David Nachbaur;Florian Kocher
- 期刊名称：《Therapeutic Advances in Hematology》 | 2020年第-1期
61.The role of belantamab mafodotin for patients with relapsed and/or refractory multiple myeloma

机译：Belantamab Mafodotin对复发和/或难治性多发性骨髓瘤患者的作用
- 作者：Melody R. Becnel;Hans C. Lee
- 期刊名称：《Therapeutic Advances in Hematology》 | 2020年第-1期
62.The value of survival gains from therapeutic innovations for US patients with relapsed/refractory multiple myeloma

机译：来自美国复发/难治性多发性骨髓瘤患者的治疗创新的生存收益价值
- 作者：Joanna P MacEwan;Istvan Majer;Jacquelyn W Chou;Sumeet Panjabi
- 期刊名称：《Therapeutic Advances in Hematology》 | 2021年第-1期
63.Features of indeterminate results of QuantiFERON-TB Gold In-Tube test in patients with haematological malignancies

机译：血液恶性肿瘤患者中氏氏素-TB金内管试验不确定结果的特征
- 作者：Chen-Cheng Huang;Chieh-Lin Jerry Teng;Ming-Feng Wu;Ching-Hsiao Lee;Hui-Chen Chen;Wei-Chang Huang
- 期刊名称：《Therapeutic Advances in Hematology》 | 2021年第-1期